7 Found Alternatives Worth Comparing Before You Pick a Weight-Loss Program

Found works for some people. But “coaching plus medication, billed separately, starting around $99 a month” is a pricing model that leaves a lot of questions unanswered before you commit. With the FDA sending warning letters to more than 30 compounding-related telehealth companies in early 2026, and a Novo Nordisk settlement in March of that year pushing many big-name platforms toward branded-only prescriptions, the field has reshuffled fast. Here are seven options worth putting side by side.

1. FormBlends

Most weight-loss telehealth platforms sell one thing: a GLP-1, maybe two. FormBlends runs a 503A compounding pharmacy model with a full catalog that includes GLP-1s, recovery peptides, growth hormone secretagogues, nootropics, and longevity compounds, all under a single clinician-supervised intake. You fill out a health history, a licensed physician reviews and prescribes, and the order ships cold-chain to you at no extra charge. Available in 47 states.

The pricing is posted before you ever create an account. Compounded semaglutide is priced per vial in the low-to-mid three-hundreds; tirzepatide sits slightly above that. No layered membership fee stacked on top. More importantly, FormBlends publishes per-product purity data tied to three distinct lab methods: HPLC (which confirms purity percentage), mass spectrometry (which verifies the molecule is what it claims to be), and endotoxin testing (which checks sterility). Semaglutide clears at 99.1% purity, tirzepatide at 99.3%. Those are product-specific numbers, not a generic certificate of analysis attached to a whole batch run.

The honest caveat: compounded medications are not FDA-approved finished products. The 503A pharmacy is FDA-inspected and operates under cGMP standards, but that is not the same as branded-drug approval. For anyone curious about peptides like BPC-157 ($54 per vial) or MK-677 ($79), human clinical evidence is thin and mostly early-stage.

Best for: People who want GLP-1 access and might also want to explore peptide therapies without jumping between separate providers.

Con: Not an insurance play. This is a cash-pay model, full stop.

2. Mochi Health

Mochi uses board-certified obesity-medicine physicians rather than general practitioners, which is a real structural difference from most platforms. Compounded semaglutide runs about $99 a month; tirzepatide around $199. They also handle branded-med prior authorizations if you have coverage. The clinical monitoring is more hands-on than many competitors.

Best for: Patients who want specialist-level oversight without paying Form Health prices.

Con: Compounded GLP-1 availability may shift with ongoing regulatory pressure in 2026.

3. Hims and Hers

After exiting compounded semaglutide following the March 2026 Novo settlement, Hims and Hers pivoted hard toward branded prescriptions. Injectable Wegovy runs about $299 a month through their platform; Zepbound closer to $399. With commercial insurance and a manufacturer savings card, those numbers can drop to almost nothing. The app is polished and onboarding is genuinely fast.

Best for: People with good commercial insurance who want a slick digital experience and branded-only medications.

Con: Cash-pay costs are high without insurance.

4. Ro Body

Ro charges roughly $39 for the first month of membership, then about $149 monthly, with medication billed on top. They have an in-house prior-authorization team, which matters more than people realize when you’re trying to get Wegovy covered. The platform is established and has been around long enough to have worked through most of the operational rough edges.

Best for: Insured patients willing to pay a membership fee in exchange for someone else handling the insurance paperwork.

Con: Month-to-month pricing adds up fast if insurance doesn’t come through.

5. Henry Meds

Henry is lean by design. Cash-pay compounded programs, first-month pricing typically in the $179 to $249 range, and a reputation for shipping quickly (often within 24 to 72 hours of approval). The tradeoff is lighter ongoing clinical monitoring compared to Mochi or Form Health.

Best for: People who want speed and simplicity and are comfortable self-directing more of their own follow-up.

Con: Less clinical hand-holding means more responsibility on the patient’s end.

6. PlushCare

PlushCare is a general telehealth platform, not a weight-loss specialist. Membership runs about $19.99 a month. They prescribe FDA-approved branded drugs like Ozempic and Wegovy, accept insurance, and offer same-day appointments in most cases. Visits, labs, and the prescriptions themselves are billed separately.

Best for: People who already have solid insurance coverage and want a low-overhead way to get a branded GLP-1 prescription.

Con: No compounded options; the low membership fee obscures the full per-visit cost.

7. Calibrate

Calibrate wraps medication into a 12-month structured program with heavy coaching and behavior-change curriculum. The program fee is separate from medication cost, and the whole model assumes you are working with insurance to cover the drug. It is the most “program” of any option on this list, in both the good and limiting senses.

Best for: Insured patients who want accountability, structure, and a long-term behavior framework alongside the medication.

Con: If insurance falls through, the economics get painful quickly. Not a flexible, pay-as-you-go setup.

A Honest Note Before You Decide

This list reflects publicly available pricing and program structures as of mid-2026. Costs change, regulations shift, and what a platform offers in your state may differ from what’s shown nationally. None of this is a substitute for a conversation with whoever manages your metabolic health. Read the fine print on billing, ask specifically what monitoring is included, and confirm availability in your state before you hand over a card number.